Anti-PD-1

5 registered clinical trials studyying Anti-PD-1 — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Unknown	Neoadjuvant Tisleizumab(BGB-A317) for dMMR/MSI-H Non-late Stage CRC Patients Before Surgery NCT06262581	Sun Yat-sen University	Phase 2
Not Yet Recruiting	Total Neoadjuvant Chemoradiotherapy Plus Anti-PD-1 in Subperitoneal Patients With Locally Advanced Rectal Canc NCT05998122	The First Hospital of Jilin University	Phase 2
Recruiting	Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC NCT05125055	Shanghai Jiao Tong University School of Medicine	Phase 2 / Phase 3
Recruiting	Neoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC Patients NCT05069857	Shanghai Jiao Tong University School of Medicine	Phase 2
Unknown	PD-1 Antibody Combined Neoadjuvant Chemotherapy for Ovarian Cancer NCT04815408	Second Affiliated Hospital, School of Medicine, Zhejiang University	Phase 2